BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35473323)

  • 1. [Recognizing IPED Use in Clinical Practice].
    Iff S; Gähwiler R; Butzke I; Quednow BB; Claussen MC
    Praxis (Bern 1994); 2022 Apr; 111(6):333-337. PubMed ID: 35473323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognizing IPED Use in Clinical Practice.
    Iff S; Gähwiler R; Butzke I; Quednow BB; Claussen MC
    Praxis (Bern 1994); 2022 Apr; 111(6):e333-e337. PubMed ID: 35473328
    [No Abstract]   [Full Text] [Related]  

  • 3. Interdisciplinary and Psychiatric Treatment of Anabolic Androgenic Steroids Users.
    Butzke I; Iff S; Zitzmann M; Quednow BB; Claussen MC
    Praxis (Bern 1994); 2022 Apr; 111(6):e339-e344. PubMed ID: 35473322
    [No Abstract]   [Full Text] [Related]  

  • 4. [Interdisciplinary and Psychiatric Treatment of Anabolic Androgenic Steroids Users].
    Butzke I; Iff S; Zitzmann M; Quednow BB; Claussen MC
    Praxis (Bern 1994); 2022 Apr; 111(6):339-344. PubMed ID: 35473320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polydrug use and polydrug markets amongst image and performance enhancing drug users: Implications for harm reduction interventions and drug policy.
    Salinas M; Floodgate W; Ralphs R
    Int J Drug Policy; 2019 May; 67():43-51. PubMed ID: 30884355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the social lives of image and performance enhancing drugs: An online ethnography of the Zyzz fandom of recreational bodybuilders.
    Underwood M
    Int J Drug Policy; 2017 Jan; 39():78-85. PubMed ID: 27768997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An exploratory study of image and performance enhancement drug use in a male British South Asian community.
    Van Hout MC; Kean J
    Int J Drug Policy; 2015 Sep; 26(9):860-7. PubMed ID: 25827056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The injecting use of image and performance-enhancing drugs (IPED) in the general population: a systematic review.
    Brennan R; Wells JSG; Van Hout MC
    Health Soc Care Community; 2017 Sep; 25(5):1459-1531. PubMed ID: 26806443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image and performance enhancing drug use among men who have sex with men and women who have sex with women in the UK.
    Hibbert MP; Brett CE; Porcellato LA; Hope VD
    Int J Drug Policy; 2021 Sep; 95():102933. PubMed ID: 32912823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systems mapping to understand complexity in the association between image and performance enhancing drugs (IPEDs) and harm.
    Bates G; Ralphs R; Bond VW; Boardley I; Hope V; Van Hout MC; McVeigh J
    Int J Drug Policy; 2022 Sep; 107():103801. PubMed ID: 35858502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The unintended consequences of emphasising blood-borne virus in research on, and services for, people who inject image and performance enhancing drugs: A commentary based on enhanced bodybuilder perspectives.
    Underwood M
    Int J Drug Policy; 2019 May; 67():19-23. PubMed ID: 30844641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the relationship between online buyers and sellers of image and performance enhancing drugs (IPEDs): Quality issues, trust and self-regulation.
    van de Ven K; Koenraadt R
    Int J Drug Policy; 2017 Dec; 50():48-55. PubMed ID: 29028563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [IPED Use in Recreational Sports].
    Iff S; Butzke I; Zitzmann M; Schneiter R; Hunziker M; Quednow BB; Claussen MC
    Praxis (Bern 1994); 2022 Apr; 111(6):345-349. PubMed ID: 35473327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Big business: The private sector market for image and performance enhancing drug harm reduction in the UK.
    Turnock L; Gibbs N; Cox L; Piatkowski T
    Int J Drug Policy; 2023 Dec; 122():104254. PubMed ID: 37950942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Insulin is super dangerous if you don't know what you're doing': Situating the risks of insulin within the image and performance enhancing drug community.
    Piatkowski T; Cox LTJ
    Drug Alcohol Rev; 2024 Apr; ():. PubMed ID: 38665042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk and blood-borne virus testing among men who inject image and performance enhancing drugs, Sydney, Australia.
    Rowe R; Berger I; Yaseen B; Copeland J
    Drug Alcohol Rev; 2017 Sep; 36(5):658-666. PubMed ID: 28244160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IPED in Recreational Sports.
    Iff S; Butzke I; Zitzmann M; Schneiter R; Hunziker M; Quednow BB; Claussen MC
    Praxis (Bern 1994); 2022 Apr; 111(6):e345-e349. PubMed ID: 35473330
    [No Abstract]   [Full Text] [Related]  

  • 18. Superheroes - Image and performance enhancing drug (IPED) use within the UK, social media and gym culture.
    Richardson A; Dixon K; Kean J
    J Forensic Leg Med; 2019 May; 64():28-30. PubMed ID: 30921558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Across the spectrum of legality: The market activities of influencers specialized in steroids and other performance and image enhancing drugs.
    Paoli L; Joseph Cox LT
    Int J Drug Policy; 2024 Jan; 123():104246. PubMed ID: 37979285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. #Sponseredathlete: the marketing of image and performance enhancing drugs on Facebook and Instagram.
    Gibbs N
    Trends Organ Crime; 2023 Mar; ():1-40. PubMed ID: 37363752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.